У нас вы можете посмотреть бесплатно Uterus यानी बच्चेदानी में गांठ क्या Cancer में बदल सकती है? | Uterine Fibroids | Sehat 1328 или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
#Sehat | Episode No: 1328 In today’s show, we are discussing following topics: 1. Uterine fibroids: What causes fibroids, where in the uterus they can develop, what symptoms women should watch for, what treatment options are available, and whether surgery is the only solution. Can fibroids turn into cancer? Guest: Dr. Rashmi Rekha Bora, Head and Senior Consultant, Gynaecologic Oncology, Dharamshila Narayana Superspeciality Hospital, Delhi. 2. Weight-loss drugs like Ozempic, Wegovy and Mounjaro are under scrutiny in India. The Directorate General of Health Services (DGHS) has issued an advisory restricting the promotion of GLP-1 drugs used for Type-2 diabetes and weight loss. Why is the government concerned about misleading ads, and what are the risks of taking GLP-1 medicines without a doctor’s advice? Guest: Dr. Shrey Srivastava, Senior Consultant, Internal Medicine, Sharda Hospital. 3. Calcium supplement overuse: What health risks can excess calcium cause, which organs may be affected, what symptoms appear with too much calcium intake, who actually needs calcium supplements, and how to take them properly for better absorption? Guest: Dr. Deepak Kumar Mishra, Director & Head, Orthopaedics, Asian Hospital. #sehat #health #uterinefibroids #calciumsupplement #glp1 00:00 -Intro 00:36 -कैंसर में बदल सकती है बच्चेदानी की गांठ? 06:03 -GLP-1 दवाओं के विज्ञापन देश में बैन 10:04 -ज़्यादा कैल्शियम सप्लीमेंट लेने के नुकसान! 12:47 -Outro The copyright ownership in the video rests with India Today Group. No third party is permitted to use the video without obtaining the permission of India Today Group. Any permission for usage can be obtained through the email ID provided here: mail@lallantop.com. न्यूज़ लेटर के लिए क्लिक करें : https://www.thelallantop.com/newsletter खबरों को विस्तार से पढ़ने के लिए क्लिक करें यहां : https://www.thelallantop.com/ Instagram: @thelallantop Facebook: @thelallantop Twitter: @TheLallantop Production: Aditi & Neha Video Editor: Goransh